Elli Lily plans to dominate the GLP-1 weight loss drug market-and it is successful.
It is Thursday morning, at 11:50 pm ET – and Ellie lily (Lly 15.58%, Stock race is closed!
This morning, the Indianapolis-based pharmaceutical giant announced that its new GLP-1 weight loss, orflipron, “statistically important efficacy results and a safety profile have been successful (ACH-1) Step 3 Tests in Testing Injectable GLP-1 drugs.”
In response to the news, Lily shares are 14.2% above, while its rivals shares in GLP -1 weight loss market, Novo nordisk (NVO -6.89%, And Viking theraputics (Vktx -0.34%,7.1% and 1.7% are falling respectively.
Ellie Lily’s new GLP -1 Wonder Drug
At the beginning of this week, as you can remember, Fizer (Pfee 1.11%, GLP-1 was recruited in his attempt to develop weight loss pill, in his study, in his study, preventing research on oral medicine a day after a patient experienced “potentially drug-induced liver injury”. On the other hand, new drug of lily, there is no such side effect and there are many good effects.
As Lily described in her press release, Orforglipron “The first oral small molecule is glucagon -like peptide -1 (GLP -1) receptor agonist, which is taken without food and water restrictions, to successfully complete a step 3 test.” Clinical data of this 40-week testing suggests that Orforglipron helped reduce the A1C blood sugar levels in patients “on average by 1.3% to 1.6%.” At the same time, a time-grain oral pill helped reduce the weight of patients by 7.9% during testing.
What is more, Lily explains: “Given that the participants had not yet reached a weight plateau when the study was over, it seems that the lack of full weight was not yet received.” Therefore, Orforglipron has maximum weight loss ability when given more time to work.
All this suggests that Orforglipron is useful Both Diabetes And Weight loss – no needle needs.
Image Source: Getty Image.
What does it mean for lily
Lily noted that the Achieve-1 study was the first of seven planned phase 3 clinical studies, it would operate GLP-1 to prove the drug and to prove effectiveness for the treatment of both diabetes and obesity, with no injection requirement. Therefore, the company is still away from commercialization of drugs.
He said, by completing the remaining six tests, Lily should give a lot of time to increase production capacity, such as “without supply obstacles will be able to launch Orforglipron worldwide”-and once once with GLP-1 tablet stay in line to do so.
What does it mean for Novo Nordisk and Viking Theraputics
It is enough to say that this will be a very big achievement for lily, expanding the addressable market for GLP -1 drugs (through ease of delivery, no needles are required) while promising that the Lily near Lily will be completely for itself -less than the first.
Unfortunately, what is good news for Ellie Lily, probably bad news for investors in Novo Nordisk and Viking Theraputics, both of them made Lily Lily Lilie in the race to develop their own easily GLP -1 diet pills. (Both Novo and Viking Are Developing such pills; They are not yet progressing in their work as Lily. Currently, the Novo has only GLP-1 drugs on the market-ozempic and wegovy- and the viking is neither.)
Lily’s insistence on the intention of allowing any supply deficit with the new Wonder Drug also indicates that the company does not intend to give an inauguration Snow and its health (HIMS 0.63%, To horn in business with a cheating oral GLP-1 tablet, because the small pharmaceutical company successfully performed a gap in the supply of lily’s mounjaro and zipbound injected into the supply of GLP-1 drugs.
Is Ellie Lily Stock a purchase?
It is right for investors to get excited today in the long story short, Elli Lily Stock. I cannot say that I am excited about the evaluation of the sky-high 60-plus value-to-Kamai of the stock. Again, for the least time, Eli Lily is running away with the GLP -1 market and is leaving Novo Nordisk, Viking Therapeutics, and even leaving her in dust.
There is no place in any stock mentioned by Rich Smith. The micle flower has a position and recommends the physical. Motley Flowers recommended Novo Nordisk and Viking Theraputics. The Motley Fool has a disclosure policy.
Dive into the ultimate world of this incredible product! Designed with care, it delivers unmatched quality to enhance your life. Whether you’re creating, this gem promises style that shines. Ideal for enthusiasts, it’s time to treat yourself! Shop now and experience the difference today! Grab It Now!
Unleash the power of this top-notch item that enhances your work! Boasting premium craftsmanship, it’s built to perform with flawless reliability. Perfect for upgrading, this treasure elevates any lifestyle. Get yours to love its charm! Shop Today!
Elevate your space with this amazing product that excels! Thoughtfully crafted for comfort, it blends innovation to enhance your needs. From its eye-catching features to its reliable functionality, it’s a winner. Order today to make it yours! Buy It Here!
Level up with this phenomenal item that’s packed with value! Engineered to provide convenience, it’s perfect for anyone seeking flair. Its innovative build ensures a memorable experience every time. Shop now and discover what makes it so special! Get Yours Now!
Embrace the excellence of this superb product that transforms your home! Boasting state-of-the-art design, it’s crafted for durability. Loved by people for its reliability, this is a must-have you’ll value. Click today to experience it! Order Today!
